CLINICAL_TRIALS
trial_result
· 2021-10-18
Clinical Trial Update: A Phase 3 Study to Evaluate the Efficacy and Safety of Triple Therapy With CJ-12420 in H. Pylori Positive Patients [Phase 3]
Summary
A Phase 3 trial evaluating triple therapy with CJ-12420 in Helicobacter pylori–positive patients has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: HK inno.N Corporation | Conditions: Helicobacter Pylori Infection | Phase 3 | Status: COMPLETED